Related Articles
Investigation of the epidermal growth factor receptor mutation rate in non‑small cell lung cancer patients and the analysis of associated risk factors using logistic regression
Comparison of the characteristics of uncommon epidermal growth factor receptor (EGFR) mutations and EGFR‑tyrosine kinase inhibitor treatment in patients with non‑small cell lung cancer from different ethnic groups
Association between epidermal growth factor receptor gene mutation status and short‑term efficacy of first‑line platinum‑containing chemotherapy in advanced non‑small cell lung cancer
Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib
Distinct epithelial growth factor receptor mutation profile in non-small‑cell lung cancer patients from the Xuanwei area of China